Skip to main content

Table 4 Factors associated with mortality at D28

From: Influence of ICU-bed availability on ICU admission decisions

 

Dead D28

N = 276

Alive D28

N = 860

Non adjusted analysis

Adjusted analysis

Crude OR

p

Adjusted OR

P

ICU

 With low refusal rate (HBA)

121 (43.8)

359 (41.7)

1

0.54

1

 

 With high refusal rate (LBA)

155 (56.2)

501 (58.3)

1.09 (0.83–1.43)

 

1.34 (0.92–1.95)

0.12

Age (mean ± SD)

67 ± 14

55 ± 19

1.04 (1.03–1.05)

<0.001

  

Sex

 Male (%)

179 (65)

489 (57)

1

 

1

 

 Female (%)

97 (35)

371 (43)

0.71 (0.54–0.95)

0.02

0.66 (0.45–0.98)

0.04

Characteristics on proposal, n (%)

 Shock

134 (48.6)

146 (17.0)

4.73 (3.51–6.37)

<0.001

1.81 (1.21–2.72)

0.004

 Catecholamine infusion

82 (29.7)

66 (7.7)

5.21 (3.63–7.48)

<0.001

  

 Glasgow score

9.8 ± 5.0

11.9 ± 4.1

0.90 (0.87–0.93)

<0.001

  

 Platelets count <50,000/dl

11 (4.0)

13 (1.5)

2.94 (1.30–6.64)

0.007

  

 Prothrombine time <30 %

24 (8.7)

14 (1.6)

6.17 (3.14–12.11)

<0.001

2.65 (1.09–6.44)

0.03

 Creatinine level >250 µmol/l

46 (16.7)

80 (9.3)

2.19 (1.48–3.25)

<0.001

  

 Jaundice

14 (5.1)

22 (2.6)

2.09 (1.05–4.15)

0.03

  

 Mechanical ventilation (all setting)

148 (53.6)

328 (38.1)

1.93 (1.46–2.54)

<0.001

  

 NIV

15 (5.4)

54 (6.3)

0.87 (0.48–1.58)

0.65

  

 Oxygen administration >10L/min

67 (24.3)

147 (17.1)

1.59 (1.14–2.21)

0.006

  

Preexisting diseases

 COPD

15 (5.4)

52 (6.0)

0.93 (0.51–1.68)

0.81

  

 Cardiac insufficiency

22 (8.0)

34 (3.9)

2.20 (1.26–3.84)

0.005

  

 Evolutive malignancy

44 (15.9)

105 (12.2)

1.42 (0.97–2.08)

0.07

  

 Cirrhosis

26 (9.4)

31 (3.6)

2.89 (1.68–4.97)

<0.001

  

 Renal failure with ERT

8 (2.9)

20 (2.3)

1.30 (0.56–2.98)

0.54

  

Mac Cabe score

 0

81 (31.4)

493 (58.4)

1

 

1

 

 1

99 (38.4)

265 (31.4)

2.27 (1.64–3.16)

<0.001

1.56 (1.02–2.37)

0.04

 2

78 (30.2)

86 (10.2)

5.52 (3.75–8.12)

<0.001

3.66 (2.21–6.06)

<0.001

SAPS2

62 ± 20

34 ± 16

1.08 (1.07–1.10)

<0.001

1.08 (1.06–1.09)

<0.001

  1. NIV non invasive ventilation, ERT extra renal therapy